Related Experiment Videos
[Genetic instability in cancer tissues analyzed by RAPD PCR]
1Department of Central Laboratory, First Affiliated Hospital of Guangdong Medical College, Zhanjiang, Guangdong Province 524001. wang.jianxun@163.net
Shi Yan Sheng Wu Xue Bao
|January 29, 2003
Summary
Random amplified polymorphic DNA (RAPD) PCR effectively detects genomic instability in various cancers, identifying new molecular markers. This method aids in understanding cancer progression and developing targeted therapies.
Area of Science:
- Molecular Biology
- Genetics
- Oncology
Context:
- Cancer is characterized by extensive genomic alterations.
- Identifying novel molecular markers is crucial for understanding carcinogenesis.
- Traditional gene therapy targeting single genes shows limited efficacy due to DNA variations.
Purpose:
- To detect genomic instabilities and screen for new molecular markers in five tumor types using RAPD PCR.
- To analyze DNA and chromosome instabilities and identify markers linked to oncogenes or tumor suppressor genes.
- To evaluate the effectiveness of different primers in detecting genomic instability.
Summary:
- RAPD PCR analysis of 128 tumor specimens revealed significant genomic changes, with an average detectability of 40-49% across five cancer types.
- Primer 2 showed high detectability (68%) for genomic instability in tumors while maintaining reproducibility in normal tissues.
- A novel sequence (AF151005) associated with allelic loss in gastric and colon cancers was identified, highlighting the concentration of genetic instabilities at specific chromosomal loci.
Impact:
- RAPD assay combined with other techniques is a valuable tool for detecting genomic instabilities and screening for novel cancer-related molecular markers.
- Findings suggest that targeting multiple genetic alterations may be necessary for effective cancer treatment.
- The study contributes to the identification of molecular markers for early cancer detection and therapeutic development.